MarketBeat
30 Oct 2026, 04:15 UTC · 2h ago
What Amrize (AMRZ) Said on Its Q3 Earnings Call
Impact · against what's priced in
Amrize faces a significant margin headwind in its Building Envelope segment, with the timeline for price-over-cost positivity pushed back to 2027. While strong aggregates pricing and ASPIRE efficiency gains provide a partial offset, the disconnect between revenue growth and EBITDA in the roofing business suggests persistent inflationary pressure.
- AMRZ−0.20
No priced-in read yet
- In context
The delay of price-over-cost positivity in the Building Envelope segment to 2027, combined with a 14.6% EBITDA decline in that segment despite revenue growth, outweighs the positive momentum in aggregates pricing and ASPIRE savings.
Read from the article alone
